\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ left\\ costovertebral\\ pain\\ upon\\ palpation\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \ \(478\)\
\-\ ua\\ trace\\ leuko\\ est\\,\\ large\\ blood\\,\\ 30mg\\/dl\\ of\\ protein\\,\\ \\&\\ wbc\\ of\\ 13\\.\ \(0\)\
\-\ ua\\ culture\\ positive\\ for\\ multiple\\ bacterial\\ growth\\ \ \(0\)\
\-\ ldh\\ 377\\ u\\/l\ \(0\)\
\-\ ast\\ \\ 36\\ u\\/l\ \(0\)\
\-\ alt\\ 29\\ u\\/l\ \(0\)\
\-\ afp\\ 0\\.7\\ u\\/l\ \(0\)\
\-\ the\\ pt\\'s\\ pyelonephritis\\ was\\ treated\\ with\\ antibiotics\\ successfully\\.\ \(0\)\
\-\ however\\,\\ the\\ incidental\\ finding\\ of\\ the\\ left\\ lobe\\ hepatic\\ mass\\ was\\ ultrasound\\ guided\\ biopsied\\ that\\ was\\ indeterminate\\ for\\ hepatic\\ adenoma\\,\\ hcc\\,\\ or\\ fnh\\ the\\ pt\\ was\\ sent\\ to\\ surgery\\ for\\ surgical\\ resection\\ of\\ the\\ mass\\.\\ \\ pt\\ improved\\ s\\/p\\ surgery\\ and\\ is\\ doing\\ well\\.\ \(0\)\
\-\ ct\\ findings\\ consistent\\ with\\ acute\\ pyelonephritis\\ involving\\ left\\ kidney\\.\\ \\ a\\ large\\ solid\\ heterogeneously\\ enhancing\\ mass\\ 14\\.1\\ x\\ 9\\.9\\ x\\ 14\\.6\\ cm\\ is\\ seen\\ in\\ the\\ left\\ upper\\ quadrant\\ which\\ is\\ associated\\ with\\ the\\ left\\ lobe\\ of\\ the\\ liver\\ displacing\\ the\\ spleen\\ \\ infra\\-medially\\.\\ \\ some\\ lower\\ attenuating\\ areas\\ near\\ the\\ center\\ of\\ this\\ lesion\\ may\\ represent\\ necrosis\\.\\ \\ no\\ calcification\\ or\\ cystic\\ components\\.\\ \\ prominent\\ vessels\\ are\\ seen\\ at\\ the\\ periphery\\ of\\ the\\ lesion\\ near\\ the\\ left\\ lobe\\ of\\ the\\ liver\\.\\ \\ the\\ remainder\\ of\\ the\\ liver\\ demonstrates\\ multiple\\ round\\ hypoattenuating\\ foci\\ of\\ varying\\ sizes\\,\\ many\\ of\\ which\\ are\\ too\\ small\\ to\\ characterize\\.\\ \ \(0\)\
\-\ \\ \ \(1082074\)\
\-\ mri\\ shows\\ multiple\\ lesions\\ in\\ the\\ liver\\ with\\ the\\ largest\\ in\\ the\\ left\\ lobe\\ with\\ similar\\ imaging\\ appearances\\ as\\ in\\ the\\ ct\\.\ \(0\)\
\-\ hepatic\\ adenoma\ \(5\)\
\-\ hepatocellular\\ adenoma\\ \\(ha\\)\ \(0\)\
\-\ focal\\ nodular\\ hyperplasia\\ \\(fnh\\)\ \(0\)\
\-\ hemangioma\ \(165\)\
\-\ hepatocellular\\ carcinoma\\ \\(hcc\\)\ \(0\)\
\-\ fibrolamellar\\ carcinoma\ \(1\)\
\-\ hepatic\\ metastases\ \(5\)\
\-\ cholangiocarcinoma\ \(16\)\
\-\ liver\\ abscess\ \(5\)\
\-\ 28\\ y\\/o\\ woman\\ with\\ no\\ significant\\ medical\\ hx\\ only\\ taking\\ ocp\\ presented\\ with\\ dysuria\\,\\ polyuria\\,\\ \\&\\ left\\ flank\\ pain\\.\ \(0\)\
\-\ hepatocellular\\ adenomas\\ \\(ha\\)\\ are\\ usually\\ large\\,\\ fatty\\,\\ well\\ circumscribed\\,\\ nonlobulated\\,\\ encapsulated\\ tumors\\.\\ \\ ha\\ are\\ typically\\ solitary\\ in\\ nature\\,\\ but\\ \\~20\\%\\ are\\ multiple\\.\\ \\ they\\ typically\\ do\\ not\\ have\\ bile\\ ducts\\ or\\ portal\\ vein\\ areas\\.\\ \\ they\\ are\\ typically\\ rows\\ of\\ heapatocytes\\.\\ \\ ha\\ can\\ develop\\ central\\ necrosis\\ and\\ hemorrhage\\ because\\ the\\ vascular\\ supply\\ is\\ often\\ restricted\\ to\\ the\\ outer\\ surface\\ of\\ the\\ tumor\\.\\ \\ typically\\ in\\ young\\ woman\\ using\\ oral\\ contraceptives\\ pills\\ \\(ocp\\)\\ ha\\ is\\ one\\ of\\ the\\ more\\ common\\ hepatic\\ neoplasm\\ as\\ in\\ this\\ patient\\.\\ \\ also\\,\\ individuals\\ with\\ hemochromatosis\\ \\,\\ glycogen\\ storage\\ disease\\,\\ acromegaly\\,\\ and\\ anabolic\\ steroids\\ users\\ with\\ a\\ hepatic\\ mass\\ are\\ likely\\ to\\ be\\ ha\\ as\\ well\\.\\ \\ some\\ believe\\ that\\ the\\ ocp\\ \\&\\ anabolic\\ steroids\\ lead\\ to\\ generalized\\ vascular\\ ectasia\\ of\\ the\\ liver\\ leading\\ to\\ the\\ development\\ of\\ ha\\.\\ \\ 80\\%\\ of\\ adenomas\\ are\\ solitary\\ and\\ 20\\%\\ are\\ multiple\\.\ \(0\)\
\-\ computed\\ tomography\\ \\(ct\\)\\ in\\ triple\\ phase\\ liver\\ dedicated\\ study\\ demonstrate\\ most\\ ha\\ as\\ a\\ lesion\\ with\\ homogeneous\\ enhancement\\ in\\ the\\ late\\ arterial\\ phase\\,\\ that\\ will\\ stay\\ isodense\\ to\\ the\\ liver\\ in\\ later\\ phases\\.\\ \\ however\\,\\ these\\ findings\\ in\\ the\\ late\\ arterial\\ phase\\ are\\ not\\ specific\\ to\\ adenomas\\,\\ since\\ hepatocellular\\ carcinoma\\ \\(hcc\\)\\,\\ hemangiomas\\,\\ hypervascular\\ metastases\\,\\ \\&\\ focal\\ nodular\\ hyperplasia\\ \\(fnh\\)\\ can\\ show\\ similar\\ enhancement\\ in\\ the\\ arterial\\ phase\\.\\ \\ the\\ finding\\ of\\ hemorrhage\\ as\\ an\\ area\\ of\\ high\\ attenuation\\ can\\ be\\ seen\\ in\\ as\\ many\\ as\\ 40\\%\\ of\\ adenomas\\.\\ \\ fat\\ deposition\\ within\\ adenomas\\ is\\ often\\ difficult\\ to\\ identify\\ on\\ ct\\ and\\ is\\ better\\ visualized\\ on\\ magnetic\\ resonance\\ imaging\\ \\(mri\\)\\.\ \(0\)\
\-\ due\\ to\\ the\\ risk\\ of\\ intraperitoneal\\ hemorrhage\\ of\\ the\\ ha\\ \\&\\ the\\ rare\\ occurrence\\ of\\ malignant\\ transformation\\ to\\ hcc\\,\\ surgical\\ resection\\ has\\ been\\ advocated\\ as\\ the\\ best\\ solution\\ for\\ patients\\ with\\ presumed\\ ha\\ as\\ was\\ done\\ in\\ this\\ case\\.\\ \\ percutaneous\\ fine\\ needle\\ biopsy\\ of\\ a\\ mass\\ suspicious\\ for\\ ha\\ is\\ controversial\\ because\\ of\\ a\\ significant\\ risk\\ hemorrhage\\ \\&\\ difficult\\ to\\ distinguish\\ from\\ fnh\\ histologically\\ \\(fnh\\ does\\ not\\ require\\ surgical\\ resection\\)\\,\\ however\\,\\ was\\ still\\ performed\\ in\\ this\\ case\\,\\ but\\ diagnosis\\ could\\ not\\ be\\ made\\ from\\ biopsy\\.\\ \\ \\ \\ also\\,\\ ha\\ may\\ also\\ decrease\\ in\\ size\\ if\\ not\\ disappear\\ after\\ ocps\\ have\\ been\\ stopped\\,\\ in\\ this\\ pt\\ the\\ lesion\\ was\\ felt\\ to\\ be\\ too\\ large\\ to\\ pursue\\ this\\ treatment\\.\\ \\ \ \(0\)\
\-\ reference\\:\ \(0\)\
\-\ richard\\ baron\\.\\ \\‚\\Ä\\úliver\\ \\:\\ masses\\ part\\ ii\\ \\:\\ common\\ liver\\ tumors\\‚\\Ä\\ù\\.\\ radiology\\ department\\ of\\ univ\\ of\\ chicago\\.\\ http\\:\\/\\/www\\.radiologyassistant\\.nl\\/en\\/448eef3083354\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ha\\:\\ 0\\.4510638986139202\ \(0\)\
\-\ the\\:\\ 0\\.2384929863897664\ \(0\)\
\-\ liver\\:\\ 0\\.2228457745561048\ \(0\)\
\-\ fnh\\:\\ 0\\.20320491847169808\ \(0\)\
\-\ adenomas\\:\\ 0\\.18794329108913344\ \(0\)\
\-\ of\\:\\ 0\\.17068559964750646\ \(0\)\
\-\ hepatic\\:\\ 0\\.15435015637005592\ \(0\)\
\-\ hcc\\:\\ 0\\.1494299365980889\ \(0\)\
\-\ ocp\\:\\ 0\\.1394150882707502\ \(0\)\
\-\ in\\:\\ 0\\.13661385870763454\ \(0\)\
\-\ hepatocellular\\:\\ 0\\.13284040269853847\ \(0\)\
\-\ are\\:\\ 0\\.12257780660181568\ \(0\)\
\-\ as\\:\\ 0\\.11679784362231661\ \(0\)\
\-\ to\\:\\ 0\\.1130620217372361\ \(0\)\
\-\ phase\\:\\ 0\\.11056835730257483\ \(0\)\
\-\ anabolic\\:\\ 0\\.09872898100475791\ \(0\)\
\-\ pt\\:\\ 0\\.09299153545384146\ \(0\)\
\-\ typically\\:\\ 0\\.09071017122863785\ \(0\)\
\-\ left\\:\\ 0\\.08815594179670044\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.08651252039015793\ \(0\)\
\-\ arterial\\:\\ 0\\.07980846070603066\ \(0\)\
\-\ multiple\\:\\ 0\\.07900218575798228\ \(0\)\
\-\ was\\:\\ 0\\.07880708708709873\ \(0\)\
\-\ adenoma\\:\\ 0\\.0772624250861232\ \(0\)\
\-\ lobe\\:\\ 0\\.07467247414740222\ \(0\)\
\-\ is\\:\\ 0\\.07077267675392558\ \(0\)\
\-\ with\\:\\ 0\\.06958012691773559\ \(0\)\
\-\ pyelonephritis\\:\\ 0\\.06709322842813897\ \(0\)\
\-\ this\\:\\ 0\\.0666007748657995\ \(0\)\
\-\ too\\:\\ 0\\.06498980410250772\ \(0\)\
\-\ large\\:\\ 0\\.0647430061530089\ \(0\)\
\-\ not\\:\\ 0\\.06376363917297467\ \(0\)\
\-\ resection\\:\\ 0\\.062121253869034714\ \(0\)\
\-\ lesion\\:\\ 0\\.061948427720826406\ \(0\)\
\-\ mass\\:\\ 0\\.06169573345192137\ \(0\)\
\-\ ua\\:\\ 0\\.061683639495873854\ \(0\)\
\-\ late\\:\\ 0\\.06098857747511312\ \(0\)\
\-\ solitary\\:\\ 0\\.059127688253593325\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.058901161571312366\ \(0\)\
\-\ carcinoma\\:\\ 0\\.05796781930582883\ \(0\)\
\-\ however\\:\\ 0\\.05736002023112561\ \(0\)\
\-\ steroids\\:\\ 0\\.056761682398339265\ \(0\)\
\-\ difficult\\:\\ 0\\.053620050962841684\ \(0\)\
\-\ near\\:\\ 0\\.05261113894251646\ \(0\)\
\-\ be\\:\\ 0\\.05241726013330282\ \(0\)\
\-\ metastases\\:\\ 0\\.05223146238872898\ \(0\)\
\-\ nonlobulated\\:\\ 0\\.05166063060279382\ \(0\)\
\-\ heapatocytes\\:\\ 0\\.05166063060279382\ \(0\)\
\-\ baron\\:\\ 0\\.05166063060279382\ \(0\)\
\-\ nodular\\:\\ 0\\.05145005212335197\ \(0\)\
\-\ many\\:\\ 0\\.050939020033419234\ \(0\)\
\-\ can\\:\\ 0\\.050855857163087353\ \(0\)\
\-\ necrosis\\:\\ 0\\.04938508609124157\ \(0\)\
\-\ 377\\:\\ 0\\.049364490502378955\ \(0\)\
\-\ users\\:\\ 0\\.049364490502378955\ \(0\)\
\-\ univ\\:\\ 0\\.049364490502378955\ \(0\)\
\-\ similar\\:\\ 0\\.049240804438675935\ \(0\)\
\-\ ct\\:\\ 0\\.04919327017002476\ \(0\)\
\-\ for\\:\\ 0\\.048955000468974316\ \(0\)\
\-\ chicago\\:\\ 0\\.04773535317460973\ \(0\)\
\-\ tumors\\:\\ 0\\.04751540000981584\ \(0\)\
\-\ surgical\\:\\ 0\\.0471019392176938\ \(0\)\
\-\ well\\:\\ 0\\.04692481579047987\ \(0\)\
\-\ leuko\\:\\ 0\\.04647169609025007\ \(0\)\
\-\ richard\\:\\ 0\\.04647169609025007\ \(0\)\
\-\ they\\:\\ 0\\.046163170878035384\ \(0\)\
\-\ risk\\:\\ 0\\.046163170878035384\ \(0\)\
\-\ seen\\:\\ 0\\.045624945106879075\ \(0\)\
\-\ also\\:\\ 0\\.04558418794657334\ \(0\)\
\-\ biopsy\\:\\ 0\\.04528746776237677\ \(0\)\
\-\ because\\:\\ 0\\.04515343120916147\ \(0\)\
\-\ rows\\:\\ 0\\.0445662611225237\ \(0\)\
\-\ advocated\\:\\ 0\\.0445662611225237\ \(0\)\
\-\ areas\\:\\ 0\\.04386392849739277\ \(0\)\
\-\ polyuria\\:\\ 0\\.04381007574642565\ \(0\)\
\-\ disappear\\:\\ 0\\.04381007574642565\ \(0\)\
\-\ ocps\\:\\ 0\\.04381007574642565\ \(0\)\
\-\ contraceptives\\:\\ 0\\.04314307297377999\ \(0\)\
\-\ glycogen\\:\\ 0\\.04314307297377999\ \(0\)\
\-\ vascular\\:\\ 0\\.04265279775138956\ \(0\)\
\-\ est\\:\\ 0\\.04254641866206598\ \(0\)\
\-\ finding\\:\\ 0\\.04246733934815384\ \(0\)\
\-\ often\\:\\ 0\\.042156309554086537\ \(0\)\
\-\ that\\:\\ 0\\.04205576823965902\ \(0\)\
\-\ costovertebral\\:\\ 0\\.04200667918399459\ \(0\)\
\-\ acromegaly\\:\\ 0\\.04200667918399459\ \(0\)\
\-\ pursue\\:\\ 0\\.04200667918399459\ \(0\)\
\-\ 20\\:\\ 0\\.041680674637514646\ \(0\)\
\-\ solution\\:\\ 0\\.041513935646010774\ \(0\)\
\-\ some\\:\\ 0\\.04065033222941528\ \(0\)\
\-\ characterize\\:\\ 0\\.04064098369433961\ \(0\)\
\-\ appearances\\:\\ 0\\.04064098369433961\ \(0\)\
\-\ pills\\:\\ 0\\.04064098369433961\ \(0\)\
\-\ storage\\:\\ 0\\.04025027856165111\ \(0\)\
\-\ believe\\:\\ 0\\.04025027856165111\ \(0\)\
\-\ attenuating\\:\\ 0\\.03988479831824156\ \(0\)\
\-\ fibrolamellar\\:\\ 0\\.03988479831824156\ \(0\)\
\-\ dedicated\\:\\ 0\\.03954148240167676\ \(0\)\
\-\ histologically\\:\\ 0\\.03954148240167676\ \(0\)\
\-\ indeterminate\\:\\ 0\\.038911614045895646\ \(0\)\
\-\ encapsulated\\:\\ 0\\.038911614045895646\ \(0\)\
\-\ focal\\:\\ 0\\.03864521287055255\ \(0\)\
\-\ hemochromatosis\\:\\ 0\\.03862114123388189\ \(0\)\
\-\ biopsied\\:\\ 0\\.0380814017558105\ \(0\)\
\-\ hypoattenuating\\:\\ 0\\.0380814017558105\ \(0\)\
\-\ triple\\:\\ 0\\.03782967238987506\ \(0\)\
\-\ been\\:\\ 0\\.0376409897165992\ \(0\)\
\-\ displacing\\:\\ 0\\.037588658217826684\ \(0\)\
\-\ trace\\:\\ 0\\.037357484149522224\ \(0\)\
\-\ significant\\:\\ 0\\.037302876352793286\ \(0\)\
\-\ enhancement\\:\\ 0\\.03718688163605364\ \(0\)\
\-\ sizes\\:\\ 0\\.0371353781028187\ \(0\)\
\-\ phases\\:\\ 0\\.0371353781028187\ \(0\)\
\-\ occurrence\\:\\ 0\\.0371353781028187\ \(0\)\
\-\ dysuria\\:\\ 0\\.03692165544518103\ \(0\)\
\-\ controversial\\:\\ 0\\.03692165544518103\ \(0\)\
\-\ common\\:\\ 0\\.036639783059260814\ \(0\)\
\-\ ectasia\\:\\ 0\\.03613931307902342\ \(0\)\
\-\ stay\\:\\ 0\\.03613931307902342\ \(0\)\
\-\ isodense\\:\\ 0\\.03613931307902342\ \(0\)\
\-\ stopped\\:\\ 0\\.03613931307902342\ \(0\)\
\-\ cholangiocarcinoma\\:\\ 0\\.035959520890057474\ \(0\)\
\-\ hemangiomas\\:\\ 0\\.03529251811741182\ \(0\)\
\-\ ldh\\:\\ 0\\.03513735832169697\ \(0\)\
\-\ distinguish\\:\\ 0\\.034986336617711555\ \(0\)\
\-\ successfully\\:\\ 0\\.03483923800240383\ \(0\)\
\-\ surgery\\:\\ 0\\.03473565859649253\ \(0\)\
\-\ identify\\:\\ 0\\.03441956616574065\ \(0\)\
\-\ doing\\:\\ 0\\.034286313469994896\ \(0\)\
\-\ intraperitoneal\\:\\ 0\\.034286313469994896\ \(0\)\
\-\ hypervascular\\:\\ 0\\.03415612432762641\ \(0\)\
\-\ afp\\:\\ 0\\.034028861033052145\ \(0\)\
\-\ imaging\\:\\ 0\\.03395336317957277\ \(0\)\
\-\ varying\\:\\ 0\\.033904394961690974\ \(0\)\
\-\ resonance\\:\\ 0\\.033904394961690974\ \(0\)\
\-\ individuals\\:\\ 0\\.033782605788644705\ \(0\)\
\-\ or\\:\\ 0\\.033713634155096685\ \(0\)\
\-\ woman\\:\\ 0\\.03364773328658733\ \(0\)\
\-\ heterogeneously\\:\\ 0\\.03354661421406949\ \(0\)\
\-\ and\\:\\ 0\\.03337580878155182\ \(0\)\
\-\ ducts\\:\\ 0\\.033320064873077794\ \(0\)\
\-\ magnetic\\:\\ 0\\.033320064873077794\ \(0\)\
\-\ mri\\:\\ 0\\.033163694833946926\ \(0\)\
\-\ transformation\\:\\ 0\\.032996378016996945\ \(0\)\
\-\ presumed\\:\\ 0\\.032996378016996945\ \(0\)\
\-\ largest\\:\\ 0\\.03289246724326674\ \(0\)\
\-\ fine\\:\\ 0\\.03289246724326674\ \(0\)\
\-\ periphery\\:\\ 0\\.03259170745607229\ \(0\)\
\-\ deposition\\:\\ 0\\.03259170745607229\ \(0\)\
\-\ may\\:\\ 0\\.03251246941062431\ \(0\)\
\-\ supply\\:\\ 0\\.03249490205125386\ \(0\)\
\-\ case\\:\\ 0\\.03245804375779292\ \(0\)\
\-\ have\\:\\ 0\\.03227492872630205\ \(0\)\
\-\ but\\:\\ 0\\.03194844898212737\ \(0\)\
\-\ findings\\:\\ 0\\.031886332062843734\ \(0\)\
\-\ guided\\:\\ 0\\.03169092754530858\ \(0\)\
\-\ reference\\:\\ 0\\.031608254861276094\ \(0\)\
\-\ spleen\\:\\ 0\\.031446444473746074\ \(0\)\
\-\ bile\\:\\ 0\\.03136724068922773\ \(0\)\
\-\ culture\\:\\ 0\\.031289129405586646\ \(0\)\
\-\ taking\\:\\ 0\\.031289129405586646\ \(0\)\
\-\ tomography\\:\\ 0\\.031289129405586646\ \(0\)\
\-\ computed\\:\\ 0\\.03113606662092326\ \(0\)\
\-\ percutaneous\\:\\ 0\\.03113606662092326\ \(0\)\
\-\ alt\\:\\ 0\\.031061059189527472\ \(0\)\
\-\ outer\\:\\ 0\\.031061059189527472\ \(0\)\
\-\ ast\\:\\ 0\\.030987032275540373\ \(0\)\
\-\ portal\\:\\ 0\\.03091396057421975\ \(0\)\
\-\ generalized\\:\\ 0\\.030841819747936927\ \(0\)\
\-\ fatty\\:\\ 0\\.03070023791658207\ \(0\)\
\-\ better\\:\\ 0\\.03049428873755656\ \(0\)\
\-\ bacterial\\:\\ 0\\.03023084689944232\ \(0\)\
\-\ sent\\:\\ 0\\.03023084689944232\ \(0\)\
\-\ protein\\:\\ 0\\.029979117533506884\ \(0\)\
\-\ needle\\:\\ 0\\.029979117533506884\ \(0\)\
\-\ develop\\:\\ 0\\.029738103361458514\ \(0\)\
\-\ hx\\:\\ 0\\.029394787444893704\ \(0\)\
\-\ which\\:\\ 0\\.029377617224832037\ \(0\)\
\-\ components\\:\\ 0\\.029339538438084622\ \(0\)\
\-\ center\\:\\ 0\\.029230631653196892\ \(0\)\
\-\ suspicious\\:\\ 0\\.028865151409787345\ \(0\)\
\-\ part\\:\\ 0\\.028865151409787345\ \(0\)\
\-\ lead\\:\\ 0\\.0287649190891126\ \(0\)\
\-\ leading\\:\\ 0\\.028715460449147214\ \(0\)\
\-\ improved\\:\\ 0\\.028666430027888202\ \(0\)\
\-\ still\\:\\ 0\\.028617820473804872\ \(0\)\
\-\ nature\\:\\ 0\\.02852183549322254\ \(0\)\
\-\ homogeneous\\:\\ 0\\.02852183549322254\ \(0\)\
\-\ remainder\\:\\ 0\\.02842745033701126\ \(0\)\
\-\ felt\\:\\ 0\\.028380841199169633\ \(0\)\
\-\ flank\\:\\ 0\\.028334612548329172\ \(0\)\
\-\ 29\\:\\ 0\\.028153381777295344\ \(0\)\
\-\ restricted\\:\\ 0\\.02776565011712449\ \(0\)\
\-\ require\\:\\ 0\\.02776565011712449\ \(0\)\
\-\ decrease\\:\\ 0\\.02776565011712449\ \(0\)\
\-\ department\\:\\ 0\\.027325196685470524\ \(0\)\
\-\ hemangioma\\:\\ 0\\.027173161291644453\ \(0\)\
\-\ surface\\:\\ 0\\.0269524978581903\ \(0\)\
\-\ represent\\:\\ 0\\.02688081363164808\ \(0\)\
\-\ 28\\:\\ 0\\.026810025481420842\ \(0\)\
\-\ do\\:\\ 0\\.02677496048839798\ \(0\)\
\-\ 36\\:\\ 0\\.02674011128131375\ \(0\)\
\-\ development\\:\\ 0\\.02670547522055996\ \(0\)\
\-\ growth\\:\\ 0\\.026636832219144216\ \(0\)\
\-\ young\\:\\ 0\\.026636832219144216\ \(0\)\
\-\ using\\:\\ 0\\.026569011309372472\ \(0\)\
\-\ round\\:\\ 0\\.026468778988697723\ \(0\)\
\-\ foci\\:\\ 0\\.026402929662095204\ \(0\)\
\-\ best\\:\\ 0\\.02599261812224037\ \(0\)\
\-\ oral\\:\\ 0\\.025872124676983715\ \(0\)\
\-\ radiology\\:\\ 0\\.025872124676983715\ \(0\)\
\-\ done\\:\\ 0\\.02569605935770131\ \(0\)\
\-\ from\\:\\ 0\\.02565931115451724\ \(0\)\
\-\ ii\\:\\ 0\\.025469510016709617\ \(0\)\
\-\ prominent\\:\\ 0\\.02544181813620029\ \(0\)\
\-\ upon\\:\\ 0\\.02541426100990053\ \(0\)\
\-\ visualized\\:\\ 0\\.025225026945147107\ \(0\)\
\-\ 80\\:\\ 0\\.025198502408225198\ \(0\)\
\-\ vessels\\:\\ 0\\.02506771187698769\ \(0\)\
\-\ circumscribed\\:\\ 0\\.025016229901701634\ \(0\)\
\-\ made\\:\\ 0\\.0249146490923243\ \(0\)\
\-\ solid\\:\\ 0\\.02476561474694141\ \(0\)\
\-\ attenuation\\:\\ 0\\.02471679566632842\ \(0\)\
\-\ specific\\:\\ 0\\.024478820387983113\ \(0\)\
\-\ rare\\:\\ 0\\.02438636154592053\ \(0\)\
\-\ incidental\\:\\ 0\\.02394544023486945\ \(0\)\
\-\ http\\:\\ 0\\.0238821660762691\ \(0\)\
\-\ antibiotics\\:\\ 0\\.02379888548302238\ \(0\)\
\-\ 40\\:\\ 0\\.02375770000490792\ \(0\)\
\-\ could\\:\\ 0\\.023497056772375593\ \(0\)\
\-\ since\\:\\ 0\\.023399919257286433\ \(0\)\
\-\ vein\\:\\ 0\\.023154893624930242\ \(0\)\
\-\ pain\\:\\ 0\\.02311889719755928\ \(0\)\
\-\ later\\:\\ 0\\.02311812090948566\ \(0\)\
\-\ calcification\\:\\ 0\\.02306340571785157\ \(0\)\
\-\ malignant\\:\\ 0\\.02302722043000621\ \(0\)\
\-\ wbc\\:\\ 0\\.0228322316495471\ \(0\)\
\-\ kidney\\:\\ 0\\.022694523264499045\ \(0\)\
\-\ involving\\:\\ 0\\.02262690481002217\ \(0\)\
\-\ quadrant\\:\\ 0\\.02262690481002217\ \(0\)\
\-\ does\\:\\ 0\\.022332232533018227\ \(0\)\
\-\ neoplasm\\:\\ 0\\.022052138058671605\ \(0\)\
\-\ masses\\:\\ 0\\.021991732384281263\ \(0\)\
\-\ size\\:\\ 0\\.021872820334812526\ \(0\)\
\-\ palpation\\:\\ 0\\.0217852467605739\ \(0\)\
\-\ central\\:\\ 0\\.021572060547618076\ \(0\)\
\-\ study\\:\\ 0\\.02154423258852553\ \(0\)\
\-\ positive\\:\\ 0\\.021286471718899507\ \(0\)\
\-\ no\\:\\ 0\\.021009583914877724\ \(0\)\
\-\ area\\:\\ 0\\.020926796681820736\ \(0\)\
\-\ will\\:\\ 0\\.02079151823814433\ \(0\)\
\-\ abscess\\:\\ 0\\.020743116419732775\ \(0\)\
\-\ medical\\:\\ 0\\.020530286342801456\ \(0\)\
\-\ show\\:\\ 0\\.02050712484515755\ \(0\)\
\-\ usually\\:\\ 0\\.02033636884492834\ \(0\)\
\-\ enhancing\\:\\ 0\\.020236333261326678\ \(0\)\
\-\ only\\:\\ 0\\.020181512133496244\ \(0\)\
\-\ treated\\:\\ 0\\.02011641971246905\ \(0\)\
\-\ fat\\:\\ 0\\.02009488744972226\ \(0\)\
\-\ ultrasound\\:\\ 0\\.019925514726951976\ \(0\)\
\-\ on\\:\\ 0\\.01951253688147721\ \(0\)\
\-\ cystic\\:\\ 0\\.019455412682341928\ \(0\)\
\-\ likely\\:\\ 0\\.019303885828873137\ \(0\)\
\-\ performed\\:\\ 0\\.01911096767031336\ \(0\)\
\-\ shows\\:\\ 0\\.01895947062505267\ \(0\)\
\-\ presented\\:\\ 0\\.01883768145200641\ \(0\)\
\-\ if\\:\\ 0\\.01876924583631496\ \(0\)\
\-\ blood\\:\\ 0\\.018760749243153525\ \(0\)\
\-\ due\\:\\ 0\\.018568765492364164\ \(0\)\
\-\ cm\\:\\ 0\\.018552374805727027\ \(0\)\
\-\ lesions\\:\\ 0\\.018552374805727027\ \(0\)\
\-\ one\\:\\ 0\\.01849537813772946\ \(0\)\
\-\ high\\:\\ 0\\.018359300027426393\ \(0\)\
\-\ these\\:\\ 0\\.018241887840693742\ \(0\)\
\-\ patients\\:\\ 0\\.018172591524600944\ \(0\)\
\-\ more\\:\\ 0\\.01773818015934355\ \(0\)\
\-\ physical\\:\\ 0\\.0175158015198806\ \(0\)\
\-\ consistent\\:\\ 0\\.0175158015198806\ \(0\)\
\-\ acute\\:\\ 0\\.017475060493226537\ \(0\)\
\-\ upper\\:\\ 0\\.017262590900953598\ \(0\)\
\-\ associated\\:\\ 0\\.017026466334861403\ \(0\)\
\-\ tumor\\:\\ 0\\.016896703380886696\ \(0\)\
\-\ most\\:\\ 0\\.016811817748791355\ \(0\)\
\-\ demonstrate\\:\\ 0\\.016793792338517508\ \(0\)\
\-\ diagnosis\\:\\ 0\\.016746003208670274\ \(0\)\
\-\ small\\:\\ 0\\.016663330524637796\ \(0\)\
\-\ lower\\:\\ 0\\.01650722016605378\ \(0\)\
\-\ exam\\:\\ 0\\.016261692998052562\ \(0\)\
\-\ demonstrates\\:\\ 0\\.01622902187889646\ \(0\)\
\-\ after\\:\\ 0\\.015671048891068587\ \(0\)\
\-\ treatment\\:\\ 0\\.015387960968099324\ \(0\)\
\-\ within\\:\\ 0\\.014878082838284568\ \(0\)\
\-\ has\\:\\ 0\\.014755383701345845\ \(0\)\
\-\ disease\\:\\ 0\\.013559940876339511\ \(0\)\
\-\ an\\:\\ 0\\.012352822085293206\ \(0\)\
\-\ at\\:\\ 0\\.012201512137687765\ \(0\)\
\-\ patient\\:\\ 0\\.010506768219290972\ \(0\)\
